Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial

2019223 citationsJournal Articlehybrid Open Access

Authors

Cancer Research UK, the National Health and Medical Research Council Australia, Breast Cancer Research Foundation, Sanofi Aventis, and AstraZeneca.

Good health and well-being

Published in: The Lancet

Volume 395, Issue 10218, pp. 117-122

Field-Weighted Citation Impact: 16.33